Market Overview

Will Mindray Medical Go Private And List In China?


In a report published Monday, JMP Securities analyst David Turkaly upgraded the rating on Mindray Medical International Ltd (NYSE: MR) from Market Underperform to Market Perform, after news of the company receiving an offer to be taken private for $30 per share.

Mindray announced that it had received an offer from Li Xiting and Cheng Minghe, its co-CEOs, along with Xu Hang, Chairman of the Board and former CEO, to take the company private for $30 per share.

"While the fundamentals of the company remain negative, in our view, the shares will likely trade on the probability of completion of the deal, in the near term…Absent any material updates, we feel the shares are fairly valued at current levels and that they should continue to trade in this range," analyst David Turkaly said.

In the report JMP Securities noted 5 key points:

  1. Although the fundamentals are poor, this is unlikely to drive the shares in the near term
  2. The offer of $30 per share represents a premium of only 9.2 percent versus the price at which the shares closed on Wednesday. Investors may push for a higher premium.
  3. The three individuals forming the buyer group hold about 27.7 percent of the shares, while controling about 63.5 percent of the voting interest.
  4. The deal has not been finalized and is subject to obtaining financing.
  5. "We believe the buyers may be looking at this as an arbitrage opportunity as it would not represent the first time a Chinese company went private and subsequently re-listed on the Chinese market (likely at a much higher multiple)," Turkaly commented.

Latest Ratings for MR

Nov 2015Standpoint ResearchDowngradesBuyHold
Jun 2015JMP SecuritiesUpgradesUnderperformMarket Perform
Mar 2015Credit SuisseDowngradesNeutralUnderperform

View More Analyst Ratings for MR
View the Latest Analyst Ratings

Posted-In: JMP SecuritiesAnalyst Color Upgrades Analyst Ratings


Related Articles (MR)

View Comments and Join the Discussion!

Latest Ratings

DRIBank of AmericaReiterates130.0
PVACNorthland SecuritiesUpgrades0.0
NKEWells FargoMaintains80.0
DRIWells FargoMaintains120.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Top 4 Small-Cap Stocks In The Education & Training Services Industry With The Highest ROE

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS